Batista, S. http://orcid.org/0000-0002-6081-6955
Nunes, C. C.
Cerqueira, J. J.
Martins Silva, Ana
Correia de Sá, J.
Ferreira, J.
Mendonça, M. T.
Pinheiro, J.
Salgado, V.
Correia, A. S.
Sequeira, J.
Costa, A.
Sousa, L.
Funding for this research was provided by:
Novartis Pharma Portugal
Article History
Received: 28 December 2019
Accepted: 15 September 2020
First Online: 30 September 2020
Change Date: 9 November 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-020-04879-4
Compliance with ethical standards
:
: Sónia Batista has received compensation as a speaker in meetings and for consulting and advisory board participation from Biogen, Bayer, Merck Serono,Novartis, Roche, and Sanofi-Genzyme.Ana Martins da Silva has received compensation as a speaker in meetings and for consulting, clinical trial research, and advisory board participation fromBiogen, Bayer, Merck Serono, Novartis, Roche, and Sanofi-Genzyme.Lívia Sousa has received compensation as a speaker in meetings and for consulting, clinical trial research, and advisory board participation from Biogen,Bayer, Merck Serono, Novartis, Roche, and Sanofi-Genzyme.
: The study protocol was approved by the local Ethics Committee. An informed consent was obtained from each participant and the research was conducted according to the principles of the Helsinki Declaration.
: An informed consent was obtained from each participant.